n°201

February 2019

Issue Contents
Editorial

Free  Research ethics and sponsors' accountability

p.31

Marketing Authorisations

Dinutuximab beta (Qarziba°) for neuro­blastoma

p.33-37
Inadequate evaluation, frequent and serious adverse effects

Midostaurin (Rydapt°) in mastocytosis

p.38-39
Appears to prolong survival in mast cell leukaemia

Free  Midostaurin (Rydapt°) for some types of acute myeloid leukaemia

p.40
Improved survival, but adverse effects underestimated

INN Common stem: -conazole

p.41

Adverse Effects

Drug-induced cholelithiasis

p.42-44

Gadolinium, MRI and pregnancy: risks for the child

p.44-46

Inset. MRI without gadolinium in a pregnant woman

p.45

Dolutegravir and pregnancy: neural tube defects

p.47

Iron tablet aspiration: bronchial necrosis

p.47

Reviews

Simple febrile seizures in a child

p.48-51
First-choice treatments

Postpartum haemorrhage

p.52
No reduction in mortality with tranexamic acid

Outlook

Psychostimulant use by medical students in France

p.53-54

Non-occupational exposure to agricultural pesticides and Parkinson's disease

p.54-55

Masthead

Free  Masthead

p.30

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe